Form 4: Encompass Health CEO Mark Tarr Executes Stock Options and Sells Shares

Encompass Health's CEO, Mark Tarr, exercised stock options and sold shares on May 20, 2025, resulting in adjustments to his holdings.

Summary

• On May 20, 2025, Mark Tarr, the President & CEO of Encompass Health Corp, engaged in transactions involving Encompass Health Common Stock.
• Tarr exercised non-qualified stock options to acquire 56,306 shares at an exercise price of $35.06 and 62,078 shares at an exercise price of $44.67.
• Following the exercise of these options, Tarr sold 94 shares at $120.94 and 118,290 shares at a weighted average price ranging from $121.03 to $121.96.
• After these transactions, Tarr directly owns 527,070 shares of Encompass Health Common Stock.
• The exercise price and number of options reported have been adjusted for the spin-off distribution of Enhabit, Inc.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The transactions themselves don't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It's common for executives to exercise stock options and sell shares for personal financial management.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• The exercise and sale of shares are typical activities, and the disclosure via Form 4 ensures compliance with SEC regulations.
• Comparing Tarr's transactions to those of executives at similar healthcare companies (e.g., Universal Health Services, HCA Healthcare) would provide further context on the scale and frequency of such activities.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
• The disclosure provides transparency to stakeholders regarding executive compensation and stock ownership.

Key Dates

Keywords

Encompass Health, Mark Tarr, Stock Options, Share Sale, Form 4, EHC, Insider Trading, Beneficial Ownership